Literature DB >> 2994386

Whole brain irradiation for metastases from lung carcinoma. A clinical investigation.

M Chatani, T Teshima, K Hata, T Inoue, T Suzuki.   

Abstract

Sixty-nine consecutive patients with brain metastases from lung carcinoma were randomly allocated to one of two radiation therapy schedules: 30 Gy/10 fractions/2 weeks or 50 Gy/20 fractions/4 weeks. The improvement rate for neurologic function was similar in the two groups. The median survival times for patients receiving the short course and the long course were 4 months and 3 months, respectively. The half-year survival rate was 42 per cent after the short course and 14 per cent after the long course (p less than 0.05). Performance status and lactate dehydrogenase were other factors which significantly influenced the half-year survival rate.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994386     DOI: 10.3109/02841868509136057

Source DB:  PubMed          Journal:  Acta Radiol Oncol        ISSN: 0349-652X


  9 in total

1.  Solitary brain metastases from non-oat cell lung cancer: clinical and prognostic features.

Authors:  M Salvati; L Cervoni; R Delfini
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

2.  The impact of tumour histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients.

Authors:  M Buglione; L Bandera; S Grisanti; N Pasinetti; P Borghetti; F Barbera; L Triggiani; L Costa; B Shehi; B Bonetti; S Magrini
Journal:  Radiol Med       Date:  2011-10-21       Impact factor: 3.469

Review 3.  The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.

Authors:  Laurie E Gaspar; Minesh P Mehta; Roy A Patchell; Stuart H Burri; Paula D Robinson; Rachel E Morris; Mario Ammirati; David W Andrews; Anthony L Asher; Charles S Cobbs; Douglas Kondziolka; Mark E Linskey; Jay S Loeffler; Michael McDermott; Tom Mikkelsen; Jeffrey J Olson; Nina A Paleologos; Timothy C Ryken; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2009-12-04       Impact factor: 4.130

Review 4.  Treatment of Brain Metastases.

Authors:  Xuling Lin; Lisa M DeAngelis
Journal:  J Clin Oncol       Date:  2015-08-17       Impact factor: 44.544

5.  Whole brain radiotherapy with a conformational external beam radiation boost for lung cancer patients with 1-3 brain metastasis: a multi institutional study.

Authors:  Nathalie Casanova; Zohra Mazouni; Sabine Bieri; Christophe Combescure; Alessia Pica; Damien C Weber
Journal:  Radiat Oncol       Date:  2010-02-18       Impact factor: 3.481

Review 6.  Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.

Authors:  May N Tsao; Wei Xu; Rebecca Ks Wong; Nancy Lloyd; Normand Laperriere; Arjun Sahgal; Eileen Rakovitch; Edward Chow
Journal:  Cochrane Database Syst Rev       Date:  2018-01-25

7.  Clinical practice guideline on the optimal radiotherapeutic management of brain metastases.

Authors:  May N Tsao; Nancy S Lloyd; Rebecca K S Wong
Journal:  BMC Cancer       Date:  2005-04-04       Impact factor: 4.430

8.  Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline.

Authors:  May N Tsao; Dirk Rades; Andrew Wirth; Simon S Lo; Brita L Danielson; Laurie E Gaspar; Paul W Sperduto; Michael A Vogelbaum; Jeffrey D Radawski; Jian Z Wang; Michael T Gillin; Najeeb Mohideen; Carol A Hahn; Eric L Chang
Journal:  Pract Radiat Oncol       Date:  2012-01-30

Review 9.  [Whole Brain Irradiation and Hypo-fractionation Radiotherapy for the Metastases in Non-small Cell Lung Cancer].

Authors:  Xingting Gu; Yaqin Zhao; Feng Xu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-04-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.